- Home
- PROK vs DIN Comparison
PROK vs DIN Comparison
Compare PROK & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | DIN |
|---|---|---|
| Founded | 2015 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.6M | 399.8M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PROK | DIN |
|---|---|---|
| Price | $1.95 | $35.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | $7.40 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 1.4M | 348.3K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | $893,000.00 | ★ $879,300,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | $0.64 |
| P/E Ratio | ★ N/A | $62.14 |
| Revenue Growth | ★ 1075.00 | 8.25 |
| 52 Week Low | $1.53 | $19.58 |
| 52 Week High | $5.95 | $39.68 |
Technical Indicators
Market Signals| Indicator | PROK | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 60.42 |
| Support Level | $1.63 | $33.47 |
| Resistance Level | $1.96 | $36.06 |
| Average True Range (ATR) | 0.17 | 1.49 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 52.07 | 68.77 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.